Monte Rosa Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of GLUE for the last quarter is 9.22 M USD, and it's 96.29% higher compared to the previous quarter. The net income of Q3 24 is -23.86 M USD.